Penserra Capital Management LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$32,000
-13.5%
1,215
+0.8%
0.00%0.0%
Q2 2021$37,000
+19.4%
1,205
+1.3%
0.00%0.0%
Q1 2021$31,000
+3.3%
1,190
-1.7%
0.00%0.0%
Q4 2020$30,000
+233.3%
1,210
+167.7%
0.00%
Q3 2020$9,000
-100.0%
452
-99.8%
0.00%
-100.0%
Q2 2018$29,030,000244,3711.83%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders